EU pumps EUR 2.9 million into cancer diagnostics project

The European Commission has awarded a grant of EUR 2.9 million to the COBRED project.

Funded under the Sixth Framework Programme (FP6), the COBRED project will aim to find new biomarkers for two of the most common cancers: colon cancer and breast cancer.

According to Dr Laszlo Takacs, CSO of BioSystems International, and COBRED coordinator, "This unprecedented project has the power to discover new cancer diagnostics. I am happy to see the enthusiasm of participating clinicians at the cancer centres, and of scientists at the academic and industrial laboratories."

The project will seek to develop the novel diagnostics for patient follow-up (monitoring markers) by exploiting the capacity of three state-of-the-art high-throughput technologies in an integrated systems biology approach.

After three years, COBRED hopes to deliver a set of biomarker/diagnostic candidates verified in preclinical studies, ready for large scale clinical validation and further development for commercialisation.

Furthermore, COBRED will seek to demonstrate the potential of exploring data from different high-throughput technologies and clinical profiles with advanced data mining technologies.

COBRED will also examine biomarkers for follow-up diagnostics, as novel diagnostic candidates may have the potential to aid early cancer detection via population screening. Additionally, the data gathered as part of the study may highlight poorly understood cancer mechanisms.

As breast cancer is the most common cancer in European women, and colorectal cancer is the third most common cancer type worldwide, diagnostics based on biomarkers have the potential to significantly improve current cancer disease management and diagnosis, providing higher accuracy at a lower cost.

The project consortium hopes this will lead to direct benefits for patients and society as a whole.

In addition to BioSystems International, the consortium comprises two other biotechnology firms, two large comprehensive cancer centres, three universities and a consultancy firm.

The project website will be up and running soon at the following address:
http://www.cobred.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...